{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:27:28Z","timestamp":1793683648404,"version":"4.5.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The association between cardiovascular (CV) disease and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is well documented. The recent work by Massicotte-Azarniouch et al. confirms the risk and adds to the existing evidence by describing the highest risk in the first 3 months after diagnosis. In this review, we aim to put their findings into perspective and formulate implications for the care of AAV patients. We discuss mechanisms for increased CV disease in AAV, including the impact of traditional risk factors and disease-related risks such as renal impairment and anti-myeloperoxidase (MPO) ANCA serotype. We also provide a brief primer on the impact of inflammatory-driven endothelial dysfunction and platelet activation on accelerated atherosclerosis in AAV patients. These features alongside the impact of disease activity and systemic inflammation provide potential explanations to why the incidence of CV events is highest in the first 3 months from diagnosis. We suggest future avenues of research, provide some suggestions to address and treat CV risk based on current evidence, and highlight the importance of addressing this topic early on. Addressing modifiable risk factors, dialogue with patients, patient information and a structured approach overall will be key to improve CV outcomes in AAV.<\/jats:p>","DOI":"10.1093\/ckj\/sfac009","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T20:14:47Z","timestamp":1641932087000},"page":"618-623","source":"Crossref","is-referenced-by-count":22,"title":["Cardiovascular disease and ANCA-associated vasculitis: are we missing a beat?"],"prefix":"10.1093","volume":"15","author":[{"given":"Lauren","family":"Floyd","sequence":"first","affiliation":[{"name":"Department of Nephrology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-6955","authenticated-orcid":false,"given":"Alexander","family":"Woywodt","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Dhaygude","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"2022033100262002500_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.114.009990","article-title":"Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study","volume":"130","author":"Dregan","year":"2014","journal-title":"Circulation"},{"key":"2022033100262002500_bib2","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"2022033100262002500_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/art.24386","article-title":"Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis","volume":"60","author":"Faurschou","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2022033100262002500_bib4","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/annrheumdis-2013-203927","article-title":"Damage in the ANCA-associated vasculitides: long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials","volume":"74","author":"Robson","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib5","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jep.12709","article-title":"Management of cardiovascular risk factors in patients with ANCA-associated vasculitis","volume":"23","author":"Bramlage","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"2022033100262002500_bib6","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib7","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/kex338","article-title":"Cardiovascular events in anti-neutrophil cytoplasmic antibody-associated vasculitis: a meta-analysis of observational studies","volume":"57","author":"Houben","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"2022033100262002500_bib8","doi-asserted-by":"crossref","first-page":"sfab229","DOI":"10.1093\/ckj\/sfab229","article-title":"Association of anti-neutrophil cytoplasmic antibody-associated vasculitis and cardiovascular events: a population-based cohort study","author":"Massicotte-Azarniouch","year":"2021","journal-title":"Clin Kidney J"},{"key":"2022033100262002500_bib9","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1093\/rheumatology\/keaa850","article-title":"Ten-year analysis of the risk of severe outcomes related to low-dose glucocorticoids in early rheumatoid arthritis","volume":"60","author":"Roubille","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"2022033100262002500_bib10","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/acr.20433","article-title":"A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis","volume":"63","author":"Suppiah","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022033100262002500_bib11","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semarthrit.2017.07.004","article-title":"The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: a study of 504 cases in a single Chinese center","volume":"47","author":"Bai","year":"2018","journal-title":"Semin Arthritis Rheum"},{"key":"2022033100262002500_bib12","first-page":"126","article-title":"Early development of new cardiovascular risk factors in the systemic vasculitides","volume":"38","author":"Monti","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"2022033100262002500_bib13","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1136\/ard.2004.033191","article-title":"Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis","volume":"64","author":"Haubitz","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0140-6736(03)12269-6","article-title":"Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis","volume":"361","author":"Woywodt","year":"2003","journal-title":"Lancet"},{"key":"2022033100262002500_bib15","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2006-06-026187","article-title":"Engulfment of apoptotic cells by microvascular endothelial cells induces proinflammatory responses","volume":"109","author":"Kirsch","year":"2006","journal-title":"Blood"},{"key":"2022033100262002500_bib16","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.101.8.841","article-title":"Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes","volume":"101","author":"Mallat","year":"2000","journal-title":"Circulation"},{"key":"2022033100262002500_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2021.03.032","article-title":"Cardiovascular events and the role of accelerated atherosclerosis in systemic vasculitis","volume":"325","author":"Clifford","year":"2021","journal-title":"Atherosclerosis"},{"key":"2022033100262002500_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-020-02321-w","article-title":"The plasma level of mCRP is linked to cardiovascular disease in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"22","author":"Wu","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2022033100262002500_bib19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1161\/01.CIR.102.13.1470","article-title":"Suppression of inflammation in primary systemic vasculitis restores vascular endothelial function: lessons for atherosclerotic disease?","volume":"102","author":"Raza","year":"2000","journal-title":"Circulation"},{"key":"2022033100262002500_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.20002","article-title":"Inflammation and arterial stiffness in systemic vasculitis: a model of vascular inflammation","volume":"50","author":"Booth","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2022033100262002500_bib21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/ard.62.2.162","article-title":"Diffuse endothelial dysfunction is common to ANCA associated systemic vasculitis and polyarteritis nodosa","volume":"62","author":"Filer","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib22","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.103.7.987","article-title":"Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure","volume":"103","author":"Guerin","year":"2001","journal-title":"Circulation"},{"key":"2022033100262002500_bib23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/ane.12787","article-title":"Accelerated atherosclerosis in ANCA-associated vasculitis","volume":"136","author":"Gonz\u00e1lez-Su\u00e1rez","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"2022033100262002500_bib24","first-page":"1875","article-title":"Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis","volume":"34","author":"Nienhuis","year":"2007","journal-title":"J Rheumatol"},{"key":"2022033100262002500_bib25","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1136\/annrheumdis-2013-203430","article-title":"Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease","volume":"73","author":"Kambas","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.34067\/KID.0000572019","article-title":"Venous thrombotic events in ANCA-associated vasculitis: incidence and risk factors","volume":"1","author":"Isaacs","year":"2020","journal-title":"Kidney360"},{"key":"2022033100262002500_bib27","doi-asserted-by":"crossref","first-page":"iii79","DOI":"10.1093\/rheumatology\/kez617","article-title":"Comorbidities in ANCA-associated vasculitis","volume":"59","author":"Kronbichler","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022033100262002500_bib28","doi-asserted-by":"crossref","first-page":"e18812","DOI":"10.1371\/journal.pone.0018812","article-title":"Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets","volume":"6","author":"Martel","year":"2011","journal-title":"PLoS One"},{"key":"2022033100262002500_bib29","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/03009742.2015.1006247","article-title":"Platelet counts as a biomarker in ANCA-associated vasculitis","volume":"44","author":"Willeke","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"2022033100262002500_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/ard.2004.034231","article-title":"Prevalence of the antiphospholipid syndrome in primary systemic vasculitis","volume":"65","author":"Rees","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/acr.22723","article-title":"Association of lupus anticoagulant with long-term damage accrual in antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"68","author":"Jordan","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2022033100262002500_bib32","article-title":"Incidence rate, predictors and outcome of Stroke in patients with ANCA associated vasculitis \u2013 a population-based study [abstract]","author":"Tabakovic","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2022033100262002500_bib33","doi-asserted-by":"crossref","first-page":"e0214150","DOI":"10.1371\/journal.pone.0214150","article-title":"Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition","volume":"14","author":"Roth Flach","year":"2019","journal-title":"PLoS One"},{"key":"2022033100262002500_bib34","doi-asserted-by":"crossref","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"2022033100262002500_bib35","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/hrt.2003.031492","article-title":"Glucocorticoid treatment and cardiovascular disease","volume":"90","author":"Ng","year":"2004","journal-title":"Heart"},{"key":"2022033100262002500_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/annrheumdis-2016-210002","article-title":"Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis","volume":"76","author":"Miloslavsky","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.34067\/KID.0000502021","article-title":"Glucocorticoid therapy in ANCA vasculitis: using the glucocorticoid toxicity index as an outcome measure","volume":"2","author":"Floyd","year":"2021","journal-title":"Kidney360"},{"key":"2022033100262002500_bib38","doi-asserted-by":"crossref","first-page":"E295\u2013E301","DOI":"10.1503\/cmaj.191012","article-title":"Oral glucocorticoids and incidence of hypertension in people with chronic inflammatory diseases: a population-based cohort study","volume":"192","author":"Mebrahtu","year":"2020","journal-title":"Can Med Assoc J"},{"key":"2022033100262002500_bib39","doi-asserted-by":"crossref","first-page":"e001267","DOI":"10.1161\/JAHA.114.001267","article-title":"Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis","volume":"3","author":"Hsue","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2022033100262002500_bib40","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/hrt.2003.020180","article-title":"Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study","volume":"90","author":"Souverein","year":"2004","journal-title":"Heart"},{"key":"2022033100262002500_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10112299","article-title":"Impact of cardiovascular risk factors on the occurrence of cardiovascular events in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides","volume":"10","author":"Roubille","year":"2021","journal-title":"J Clin Med"},{"key":"2022033100262002500_bib42","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/CIRCULATIONAHA.104.482570","article-title":"Biomarkers of cardiovascular disease","volume":"113","author":"Vasan","year":"2006","journal-title":"Circulation"},{"key":"2022033100262002500_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12968-016-0315-5","article-title":"T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides","volume":"19","author":"Greulich","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022033100262002500_bib44","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10554-020-02066-2","article-title":"Cardiac magnetic resonance imaging for the detection of myocardial involvement in granulomatosis with polyangiitis","volume":"37","author":"Giollo","year":"2021","journal-title":"Int J Cardiovasc Imaging"},{"key":"2022033100262002500_bib45","first-page":"1","article-title":"Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme","volume":"3","author":"Ruilope","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"2022033100262002500_bib46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/ndt\/gfh563","article-title":"Histological and clinical predictors of early and late renal outcome in ANCA-associated vasculitis","volume":"20","author":"Neumann","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"2022033100262002500_bib47","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.kint.2018.04.004","article-title":"Aliskiren inhibits renin-mediated complement activation","volume":"94","author":"B\u00e9k\u00e1ssy","year":"2018","journal-title":"Kidney Int"},{"key":"2022033100262002500_bib48","first-page":"annrheumdis-2021","article-title":"Call for action in ANCA-associated vasculitis and lupus nephritis: promises and challenges of SGLT-2 inhibitors","author":"S\u00e4emann","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"2022033100262002500_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2005.06.019","article-title":"Statins prevent NF-kappaB transactivation independently of the IKK-pathway in human endothelial cells","volume":"185","author":"H\u00f6lschermann","year":"2006","journal-title":"Atherosclerosis"},{"key":"2022033100262002500_bib50","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1681\/ASN.2016060690","article-title":"Endothelial NF-kB blockade abrogates ANCA-induced GN","volume":"28","author":"Choi","year":"2017","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfac009\/42927086\/sfac009.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/4\/618\/43057878\/sfac009.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/15\/4\/618\/43057878\/sfac009.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:27:06Z","timestamp":1648686426000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/15\/4\/618\/6506473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":50,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,1,13]]},"published-print":{"date-parts":[[2022,3,31]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfac009","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4]]},"published":{"date-parts":[[2022,1,13]]}}}